Dr. Jonathan Schatz, MD – Miami, FL
Oncogene Overdose: Too Much of a Bad Thing for Oncogene-Addicted Cancer Cells
Amin AD, Rajan SS, Groysman MJ, Pongtornpipat P, Schatz JH, Biomarkers in Cancer, 1/15/2015Kinase overexpressing cancers responsive to drug withdrawal
Amin AD, Rajan SS, Schatz JH, Aging, 1/1/2015Evidence suggesting that discontinuous dosing of ALK kinase inhibitors may prolong control of ALK+ tumors
Amin AD, Rajan SS, Lang WS, Pongtornpipat P, Groysman MJ, Tapia EO, Tula-Sanchez AA, Peters TL, Cuyugan L, Adkins J, Rimsza LM, Lussier YA, Puvvada SD, Schatz JH, Cancer Research, 1/1/2015
